NCT07210775 2026-03-04
Topical Imiquimod Treatment of Oral Dysplasia
University of Southern California
Phase 1/2 Recruiting
Clinical Trials
12 trialsNCT03603223 2025-07-30
Pembrolizumab in Treating Participants With Leukoplakia
Jonsson Comprehensive Cancer Center
Phase 2 Recruiting
NCT05536037 2025-05-15
Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions
Thomas Jefferson University
Phase 1 Terminated
NCT05296941 2023-09-08
PMOD
Dalarna County Council, Sweden
Phase NA Recruiting
NCT04148651 2022-03-22
The CO2RE® System for Vulvar Lichen Sclerosus
Candela Corporation
Phase NA Completed
NCT03990636 2019-06-19
PDTMALAC
Instituto Nacional de Cancer, Brazil
Phase 2 Unknown
NCT03233165 2017-07-28
Comparison Between Two Different High Power Ablative Lasers in the Treatment of Oral Leukoplakia
University of Zagreb
Phase NA Completed
NCT01497951 2017-05-17
PDT
Medical University of Vienna
Phase 3 Completed
NCT02737176 2016-08-01
TISOD
Association for the Japanese Academy of Maxillofacial Implants
Phase NA Unknown
NCT00571974 2015-03-24
Treatment of Oral Premalignant Lesions With 5-ALA PDT
University of Arkansas
Phase 1/2 Completed
NCT00155337 2012-12-21
Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia
National Taiwan University Hospital
Phase 4 Completed
NCT00001698 2008-03-04
Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR
National Institutes of Health Clinical Center (CC)
Phase 2 Completed